Skip to content

Nuvation Bio Inc.

NUVB

CIK 0001811063

← back to feed
Revenue (TTM)
$104.27M
+699.0% YoY Q1 Apr 2026
Net Income (TTM)
−$162.64M
+64.0% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.48
+71.6% YoY Q1 Apr 2026
Gross Margin
11.7%
Q1 Apr 2026
Operating Margin
-168.0%
Q1 Apr 2026
Net Margin
-156.0%
Q1 Apr 2026
Free Cash Flow (TTM)
—
Q1 Apr 2026
Cash
$125.39M
Q1 Apr 2026
Total Debt
$53.12M
Q1 Apr 2026
Shares Outstanding
348.2M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings